A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients with Type 2 Diabetes Mellitus
Clinical Trial Grant
Awarded By
Ligand Pharmaceuticals, Inc.
Start Date
October 19, 2016
End Date
October 31, 2017
Awarded By
Ligand Pharmaceuticals, Inc.
Start Date
October 19, 2016
End Date
October 31, 2017